CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+4.23%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$10.2B
AUM Growth
+$10.2B
(+2.3%)
Cap. Flow
-$47.7M
Cap. Flow
% of AUM
-0.47%
Top 10 Holdings %
Top 10 Hldgs %
71.27%
Holding
101
New
7
Increased
18
Reduced
30
Closed
9
Top Buys
| 1 |
Fiserv
FI
|
$387M |
| 2 |
Trip.com Group
TCOM
|
$45.5M |
| 3 |
Teladoc Health
TDOC
|
$10M |
| 4 |
Amazon
AMZN
|
$6.79M |
| 5 |
Karyopharm Therapeutics
KPTI
|
$6.31M |
Top Sells
| 1 |
Coca-Cola
KO
|
$389M |
| 2 |
Visa
V
|
$23.8M |
| 3 |
Microsoft
MSFT
|
$21.5M |
| 4 |
Merck
MRK
|
$15.3M |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$10.8M |
Sector Composition
| 1 | Consumer Discretionary | 18.06% |
| 2 | Financials | 17.97% |
| 3 | Healthcare | 15.31% |
| 4 | Technology | 13.48% |
| 5 | Communication Services | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Weyerhaeuser
WY
$17.9B
| $36M | 0.35% |
1,009,876
-100,880
| -9% | -$3.59M |
|
27
DexCom
DXCM
$30.9B
| $34.9M | 0.34% |
97,000
| – | – |
|
28
Exact Sciences
EXAS
$9.33B
| $33.9M | 0.33% |
256,864
-30,000
| -10% | -$3.95M |
|
29
Intuitive Surgical
ISRG
$158B
| $31M | 0.3% |
41,937
| – | – |
|
30
Edwards Lifesciences
EW
$47.7B
| $28.5M | 0.28% |
341,311
| – | – |
|
31
Centene
CNC
$14.8B
| $26.5M | 0.26% |
414,756
| – | – |
|
32
New Oriental
EDU
$7.98B
| $26.3M | 0.26% |
1,877,876
+1,692,294
| +912% | +$309K |
|
33
TAL Education Group
TAL
$6.34B
| $25.8M | 0.25% |
478,444
+13,190
| +3% | +$710K |
|
34
Teleflex
TFX
$5.57B
| $24.1M | 0.24% |
58,000
| – | – |
|
|
AXNX
35
DELISTED
Axonics, Inc. Common Stock
AXNX
| $24M | 0.23% |
400,000
| – | – |
|
36
Vertex Pharmaceuticals
VRTX
$102B
| $23.3M | 0.23% |
108,557
+20,000
| +23% | +$4.3M |
|
37
Illumina
ILMN
$15.2B
| $22.3M | 0.22% |
57,978
| – | – |
|
|
LHCG
38
DELISTED
LHC Group LLC
LHCG
| $21.2M | 0.21% |
110,657
| – | – |
|
|
AERI
39
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $20.7M | 0.2% |
1,156,142
-300,000
| -21% | -$5.36M |
|
40
QuidelOrtho
QDEL
$1.87B
| $20.5M | 0.2% |
160,000
+25,000
| +19% | +$3.2M |
|
41
Heron Therapeutics
HRTX
$204M
| $19.5M | 0.19% |
1,202,069
| – | – |
|
42
Insulet
PODD
$24.2B
| $19M | 0.19% |
72,908
| – | – |
|
|
43
Teladoc Health
TDOC
$1.37B
| $17.3M | 0.17% |
95,000
+55,000
| +138% | +$10M |
|
|
BHVN
44
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $16.9M | 0.17% |
247,498
+60,000
| +32% | +$4.1M |
|
45
NovoCure
NVCR
$1.35B
| $16.8M | 0.16% |
126,784
-35,000
| -22% | -$4.63M |
|
46
Glaukos
GKOS
$5.42B
| $16.6M | 0.16% |
197,212
-50,000
| -20% | -$4.2M |
|
47
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $15.5M | 0.15% |
1,058,464
| – | – |
|
48
Align Technology
ALGN
$9.59B
| $15.4M | 0.15% |
28,428
| – | – |
|
|
TVRD
49
Tvardi Therapeutics, Inc. Common Stock
TVRD
$270M
| $15.3M | 0.15% |
703,460
| – | – |
|
50
Krystal Biotech
KRYS
$4.35B
| $14.3M | 0.14% |
185,809
| – | – |
|